Sirolimus Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

May 2019| TMR1614A| Transparency

Report Highlights

Global Sirolimus Market: Overview

The global sirolimus market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on application, distribution channel, and region.

A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global sirolimus market.

Global Sirolimus Market: Key Segments

In terms of application, the global sirolimus market has been segmented into organ transplant rejection, lymphangioleiomyomatosis (LAM), and sirolimus coated balloons & catheter devices.
Based on distribution channel, the market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is anticipated to expand at a high CAGR during the forecast period.
The market has been analyzed based on price variations, technology trends, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year.
Global Sirolimus Market: Regional Outlook

In terms of region, the global sirolimus market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, and Rest of Middle East & Africa).
The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report

The report also profiles players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the global sirolimus market include Pfizer, Inc., Biocon, Dr. Reddy’s Laboratories Ltd., Concept Medical, Inc., Stentys SA, Torrent Pharmaceuticals Ltd., Zydus Cadila, and Intas Pharmaceuticals Ltd.

The global Sirolimus market has been segmented as follows:

Global Sirolimus Market, by Application

Organ Transplant Rejection
Lymphangioleiomyomatosis (LAM)
Sirolimus Coated Balloons & Catheter Devices
Global Sirolimus Market, by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Sirolimus Market, by Region

North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa

  • Table 1 : Pipeline Analysis
  • Table 2 : Pipeline Analysis
  • Table 3 : Pipeline Analysis
  • Table 4 : Pipeline Analysis
  • Table 5 : Pipeline Analysis
  • Table 6 : Pipeline Analysis
  • Table 7 : Pipeline Analysis
  • Table 8 : Pipeline Analysis
  • Table 9 : Pipeline Analysis
  • Table 10 : Pipeline Analysis
  • Table 11 : Global Sirolimus Market Value (US$ Mn) Forecast, by Application,2017-2027
  • Table 12 : Global Sirolimus Market Size (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 13 : Global Sirolimus Market Size (US$ Mn) Forecast, by Region,2017-2027
  • Table 14 : North America Sirolimus Market Revenue (US$ Mn) Forecast, by Country,2017-2027
  • Table 15 : North America Sirolimus Market Revenue (US$ Mn) Forecast, by Application,2017-2027
  • Table 16 : North America Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 17 : Europe Sirolimus Market Revenue (US$ Mn) Forecast, by Country,2017-2027
  • Table 18 : Europe Sirolimus Market Revenue (US$ Mn) Forecast, by Application,2017-2027
  • Table 19 : Europe Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 20 : Asia Pacific Sirolimus Market Revenue (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 21 : Asia Pacific Sirolimus Market Revenue (US$ Mn) Forecast, by Application,2017-2027
  • Table 22 : Asia Pacific Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 23 : Latin America Sirolimus Market Revenue (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 24 : Latin America Sirolimus Market Revenue (US$ Mn) Forecast, by Application,2017-2027
  • Table 25 : Latin America Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Table 26 : Middle East & Africa Sirolimus Market Revenue (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 27 : Middle East & Africa Sirolimus Market Revenue (US$ Mn) Forecast, by Application,2017-2027
  • Table 28 : Middle East & Africa Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel,2017-2027
  • Figure 1 : Global Sirolimus Market Value (US$ Mn) and Distribution, by Region, 2019 and 2027
  • Figure 2 : Market Snapshot
  • Figure 3 : Global Sirolimus Market Value Share, by Application (2018)
  • Figure 4 : Global Sirolimus Market Value Share, by Distribution Channel (2018)
  • Figure 5 : Global Sirolimus Market Value Share, by Region (2018)
  • Figure 6 : Global Sirolimus Market Size (US$ Mn) Forecast,2017-2027
  • Figure 7 : Global Sirolimus Market Value Share Analysis, by Application, 2018 and 2027
  • Figure 8 : Global Sirolimus Market Revenue (US$ Mn) Forecast,2017-2027, by Organ Transplant Rejection
  • Figure 9 : Global Sirolimus Market Revenue (US$ Mn) Forecast,2017-2027, by Lymphangioleiomyomatosis (LAM)
  • Figure 10 : Global Sirolimus Market Revenue (US$ Mn) Forecast,2017-2027, by Sirolimus Coating Balloon & Catheter Devices
  • Figure 11 : Global Sirolimus Market Attractiveness, by Application, 2019–2027
  • Figure 12 : Global Sirolimus Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 13 : Global Sirolimus Market Revenue (US$ Mn) Forecast, by Hospital Pharmacies,2017-2027
  • Figure 14 : Global Sirolimus Market Revenue (US$ Mn) Forecast, by Retail Pharmacies,2017-2027
  • Figure 15 : Global Sirolimus Market Revenue (US$ Mn) Forecast, by Online Pharmacies,2017-2027
  • Figure 16 : Global Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 17 : Global Sirolimus Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 18 : Sirolimus Market Attractiveness Analysis, by Region
  • Figure 19 : North America Sirolimus Market Revenue (US$ Mn) Forecast,2017-2027
  • Figure 20 : North America Sirolimus Market Value Share (%), by Country, 2018 and 2027
  • Figure 21 : North America Sirolimus Market Attractiveness, by Country, 2019–2027
  • Figure 22 : North America Sirolimus Market Value Share (%), by Application, 2018 and 2027
  • Figure 23 : North America Sirolimus Market Attractiveness, by Application, 2019–2027
  • Figure 24 : North America Sirolimus Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 25 : North America Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 26 : Europe Sirolimus Market Revenue (US$ Mn) Forecast,2017-2027
  • Figure 27 : Europe Sirolimus Market Value Share (%), by Country/Sub-region, 2018 and 2027
  • Figure 28 : Europe Sirolimus Market Attractiveness, by Country, 2019–2027
  • Figure 29 : Europe Sirolimus Market Value Share (%), by Application, 2018 and 2027
  • Figure 30 : Europe Sirolimus Market Attractiveness, by Application, 2019–2027
  • Figure 31 : Europe Sirolimus Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 32 : Europe Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 33 : Asia Pacific Sirolimus Market Revenue (US$ Mn) Forecast,2017-2027
  • Figure 34 : Asia Pacific Sirolimus Market Value Share (%), by Country/Sub-region, 2018 and 2027
  • Figure 35 : Asia Pacific Sirolimus Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 36 : Asia Pacific Sirolimus Market Value Share (%), by Application, 2018 and 2027
  • Figure 37 : Asia Pacific Sirolimus Market Attractiveness, by Application, 2019–2027
  • Figure 38 : Asia Pacific Sirolimus Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 39 : Asia Pacific Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 40 : Latin America Sirolimus Market Revenue (US$ Mn) Forecast,2017-2027
  • Figure 41 : Latin America Sirolimus Market Value Share (%), by Country/Sub-region, 2018 and 2027
  • Figure 42 : Latin America Sirolimus Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 43 : Latin America Sirolimus Market Value Share (%), by Application, 2018 and 2027
  • Figure 44 : Latin America Sirolimus Market Attractiveness, by Application, 2019–2027
  • Figure 45 : Latin America Sirolimus Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 46 : Latin America Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 47 : Middle East & Africa Sirolimus Market Revenue (US$ Mn) Forecast,2017-2027
  • Figure 48 : Middle East & Africa Sirolimus Market Value Share (%), by Country/Sub-region, 2018 and 2027
  • Figure 49 : Middle East & Africa Sirolimus Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 50 : Middle East & Africa Sirolimus Market Value Share (%), by Application, 2018 and 2027
  • Figure 51 : Middle East & Africa Sirolimus Market Attractiveness, by Application, 2019–2027
  • Figure 52 : Middle East & Africa Sirolimus Market Value Share (%), by Distribution Channel, 2018 and 2027
  • Figure 53 : Middle East & Africa Sirolimus Market Attractiveness, by Distribution Channel, 2019–2027
  • Figure 54 : Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 55 : Pfizer, Inc. Breakdown of Net Sales (%), by Region, 2018
  • Figure 56 : Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 57 : Pfizer, Inc. Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 58 : Biocon Branded Formulations Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 59 : Biocon Breakdown of Net Sales (%), by Region, 2018
  • Figure 60 : Biocon R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 61 : Biocon Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 62 : Dr. Reddy’s Laboratories Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 63 : Dr. Reddy’s Laboratories Ltd. Breakdown of Net Sales (% Share), by Region (2018)
  • Figure 64 : Dr. Reddy’s Laboratories Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 65 : Dr. Reddy’s Laboratories Ltd. Breakdown of Net Sales (% Share), by Business Segment (2018)
  • Figure 66 : Zydus Cadila Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 67 : Zydus Cadila Breakdown of Net Sales (%), by Region, 2018
  • Figure 68 : Zydus Cadila Pharmaceutical Business Segment R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 69 : Intas Pharmaceuticals Ltd. Intas Pharmaceuticals Ltd. Pharmaceuticals Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 70 : STENTYS SA Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 71 : STENTYS SA R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 72 : Torrent Pharmaceuticals Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 73 : Torrent Pharmaceuticals Ltd. Breakdown of Net Sales (%), by Region, 2018
  • Figure 74 : Torrent Pharmaceuticals Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report